Skip to main content

Atrovent Nasal Side Effects

Generic name: ipratropium nasal

Medically reviewed by Last updated on Mar 1, 2024.

Note: This document contains side effect information about ipratropium nasal. Some dosage forms listed on this page may not apply to the brand name Atrovent Nasal.

Applies to ipratropium nasal: nasal spray.

Serious side effects of Atrovent Nasal

Along with its needed effects, ipratropium nasal (the active ingredient contained in Atrovent Nasal) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking ipratropium nasal:

For the 0.03% nasal spray

More common

Less common


Incidence not known

For the 0.06% nasal spray used for 4 days

Less common


Other side effects of Atrovent Nasal

Some side effects of ipratropium nasal may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For the 0.03% nasal spray

Less common or rare

For the 0.06% nasal spray

Less common or rare

For Healthcare Professionals

Applies to ipratropium nasal: nasal spray.


The most frequently reported side effects were nasal dryness, epistaxis, headache, nasal discomfort, and throat irritation.[Ref]

Additional side effects have been reported from published literature and/or postmarketing surveillance when this drug was used alone or in combination with albuterol, including: urinary retention, prostatic disorders, mydriasis, cases of precipitation or worsening of narrow-angle glaucoma, acute eye pain, ocular irritation, wheezing, dryness of the oropharynx, tachycardia, edema, gastrointestinal distress (diarrhea, nausea, vomiting), bowel obstruction, constipation, nasal discomfort, throat irritation, hypersensitivity, accommodation disorder, intraocular pressure increased, glaucoma, halo vision, conjunctival hyperemia, corneal edema, heart rate increased, bronchospasm, pharyngeal edema, gastrointestinal motility disorder, mouth edema, stomatitis, and pruritus. After oral inhalation in patients suffering from chronic obstructive pulmonary disease (COPD)/asthma, supraventricular tachycardia and atrial fibrillation have been reported.[Ref]


Common (1% to 10%): Upper respiratory tract infection, epistaxis, nasal dryness, nasal irritation, nasal congestion, rhinorrhea increased, rhinitis increased, posterior nasal drip, sneezing, nasal polyps, nasal edema, pharyngitis, sinusitis, nasal discomfort, ulcerative rhinitis

Uncommon (0.1% to 1%): Bronchospasm, laryngospasm, pharyngeal edema

Frequency not reported: Hoarseness, cough, nasal burning[Ref]


Uncommon (0.1% to 1%): Vision blurred, mydriasis, intraocular pressure increased, glaucoma, eye pain, halo vision, conjunctival hyperemia, corneal edema, accommodation disorder

Frequency not reported: Ocular irritation, conjunctivitis[Ref]


Frequency not reported: Irritation[Ref]

Nervous system

Common (1% to 10%): Headache, taste perversion

Uncommon (0.1% to 1%): Dizziness[Ref]


Uncommon (0.1% to 1%): Urinary retention[Ref]


Uncommon (0.1% to 1%): Supraventricular tachycardia, atrial fibrillation, heart rate increased

Rare (less than 0.1%): Palpitation

Frequency not reported: Tachycardia[Ref]


Common (1% to 10%): Nausea, dry mouth/throat, diarrhea, throat irritation

Uncommon (0.1% to 1%): Gastrointestinal motility disorder, stomatitis

Frequency not reported: Dry mouth/throat[Ref]


Uncommon (0.1% to 1%): Angioedema of throat/tongue/lips/face, rash

Rare (less than 0.1%): Urticaria, pruritus[Ref]


Uncommon (0.1% to 1%): Hypersensitivity, anaphylactic reaction[Ref]


Common (1% to 10%): Pain

Frequency not reported: Thirst, tinnitus[Ref]


1. "Product Information. Atrovent Nasal (ipratropium nasal)." Boehringer-Ingelheim

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. (2017) "Product Information. Ipratropium Bromide Nasal (ipratropium nasal)." West-Ward Pharmaceuticals Corporation (previously Roxane Laboratories Inc)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.